化合物 Infigratinib acetate T71002
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1310746-17-8 | ¥17,500.00 | 询底价 |
25 mg | 1310746-17-8 | ¥10,600.00 | 询底价 |
50 mg | 1310746-17-8 | ¥13,800.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Infigratinib acetate
描述: Infigratinib acetate, also known as, BGJ398 acetate or NVP-BGJ398 acetate, is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities. pan FGFR kinase inhibitor BGJ398 selectively binds to and inhibits the activities of FGFRs, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Infigratinib acetate was approved in 2021 to treat adults with cholangiocarcinoma whose disease meets certain criteria.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: BGJ 398 monohydrate | BGJ-398 monohydrate | BGJ398 monohydrate | Infigratinib Acetate
化合物 Infigratinib acetate T71002信息由TargetMol中国为您提供,如您想了解更多关于化合物 Infigratinib acetate T71002报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途